Actualités
MSH wins the “Argus d'Or de l'Assurance” 2024 award for its “All Staff” Health Check-Up
News - Publiée le 30 aprile 2024
MSH, a subsidiary of the DIOT-SIACI Group and a world leader in international medical and personal risk insurance launched the “MSH All Staff” Health Check-Up in 2023, a service that can be offered to all company employees. It is based on a unique process combining digital and physical health checks.
Every year, the Argus d'Or awards recognize the best innovations in the insurance sector with the “MSH All Staff” Health Check-Up winning the prize in the Personal Insurance/Corporate Health and Life Insurance category.
Since 2020, MSH has been offering "Expatriate Health Check-Ups" to company employees before they go to work abroad to ensure their state of health is compatible with the health conditions in their destination country or countries. It is also offered during their time working abroad to confirm that their state of health remains compatible with the health conditions in their destination country or countries.
While the entire current process is highly digitalized, the health check-up is conducted face-to-face – at the health check center chosen by the employee - within MSH's extensive worldwide network. Until now, this service had been too costly to be made available to all company employees.
Faced with this situation, MSH decided to innovate by offering “All Staff” health checks, making it possible to provide the service to all company employees at a reasonable cost, and with an optimal level of medical quality. This new offering is based on a process that combines digital and physical health checks.
“MSH All Staff” is a real social innovation because, for the first time, it is available to all employees, regardless of their nationality or position in the company. This wider access to an entire employee population is part of a real health risk prevention strategy.
The “phygital” combination of online and face-to-face health checks means all employees can benefit from this dual approach. This innovation is also based on a combination of MSH's skills with those of Eutelmed, a major international player in the field of mental health and quality of working life, which has developed a range of digitalized health checks.
Finally, an additional option is being offered to employees suffering from stage 3 or 4 cancers to provide them with cutting-edge medical support. This support includes access to the latest global advances in cancer treatment and the optimization of medical protocols based on advanced medical analysis (genetic profiling). Similar options are currently being explored for other critical/chronic illnesses.
Since 2020, MSH has been offering "Expatriate Health Check-Ups" to company employees before they go to work abroad to ensure their state of health is compatible with the health conditions in their destination country or countries. It is also offered during their time working abroad to confirm that their state of health remains compatible with the health conditions in their destination country or countries.
While the entire current process is highly digitalized, the health check-up is conducted face-to-face – at the health check center chosen by the employee - within MSH's extensive worldwide network. Until now, this service had been too costly to be made available to all company employees.
Faced with this situation, MSH decided to innovate by offering “All Staff” health checks, making it possible to provide the service to all company employees at a reasonable cost, and with an optimal level of medical quality. This new offering is based on a process that combines digital and physical health checks.
“MSH All Staff” is a real social innovation because, for the first time, it is available to all employees, regardless of their nationality or position in the company. This wider access to an entire employee population is part of a real health risk prevention strategy.
The “phygital” combination of online and face-to-face health checks means all employees can benefit from this dual approach. This innovation is also based on a combination of MSH's skills with those of Eutelmed, a major international player in the field of mental health and quality of working life, which has developed a range of digitalized health checks.
Finally, an additional option is being offered to employees suffering from stage 3 or 4 cancers to provide them with cutting-edge medical support. This support includes access to the latest global advances in cancer treatment and the optimization of medical protocols based on advanced medical analysis (genetic profiling). Similar options are currently being explored for other critical/chronic illnesses.
Cet article vous a-t-il été utile ?